Sarepta Therapeutics Inc. (SRPT)
NASDAQ: SRPT
· Real-Time Price · USD
18.26
0.33 (1.84%)
At close: Sep 24, 2025, 3:59 PM
18.25
-0.05%
After-hours: Sep 24, 2025, 07:59 PM EDT
1.84% (1D)
| Bid | 18.1 |
| Market Cap | 1.78B |
| Revenue (ttm) | 2.48B |
| Net Income (ttm) | -57.96M |
| EPS (ttm) | -0.68 |
| PE Ratio (ttm) | -26.85 |
| Forward PE | 7.47 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 18.29 |
| Volume | 5,033,315 |
| Avg. Volume (20D) | 12,176,353 |
| Open | 18.03 |
| Previous Close | 17.93 |
| Day's Range | 17.51 - 18.46 |
| 52-Week Range | 10.42 - 138.81 |
| Beta | 0.49 |
| Ex-Dividend Date | n/a |
About SRPT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SRPT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SRPT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsSarepta Therapeutics Inc. is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-2.53%
Sarepta Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
1 month ago
+5.81%
Shares of several biotechnology stocks are trading higher amid Vinay Prasad's departure as director of the FDA's Center for Biologics Evaluation and Research.
